{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T20:07:11Z","timestamp":1762459631250,"version":"3.37.3"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,5,10]],"date-time":"2018-05-10T00:00:00Z","timestamp":1525910400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Genet"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12881-018-0589-6","type":"journal-article","created":{"date-parts":[[2018,5,10]],"date-time":"2018-05-10T09:43:57Z","timestamp":1525945437000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Classical fragile-X phenotype in a female infant disclosed by comprehensive genomic studies"],"prefix":"10.1186","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6507-222X","authenticated-orcid":false,"given":"Paula","family":"Jorge","sequence":"first","affiliation":[]},{"given":"Elsa","family":"Garcia","sequence":"additional","affiliation":[]},{"given":"Ana","family":"Gon\u00e7alves","sequence":"additional","affiliation":[]},{"given":"Isabel","family":"Marques","sequence":"additional","affiliation":[]},{"given":"Nuno","family":"Maia","sequence":"additional","affiliation":[]},{"given":"B\u00e1rbara","family":"Rodrigues","sequence":"additional","affiliation":[]},{"given":"Helena","family":"Santos","sequence":"additional","affiliation":[]},{"given":"Jacinta","family":"Fonseca","sequence":"additional","affiliation":[]},{"given":"Gabriela","family":"Soares","sequence":"additional","affiliation":[]},{"given":"Cec\u00edlia","family":"Correia","sequence":"additional","affiliation":[]},{"given":"Margarida","family":"Reis-Lima","sequence":"additional","affiliation":[]},{"given":"Vincenzo","family":"Cirigliano","sequence":"additional","affiliation":[]},{"given":"Ros\u00e1rio","family":"Santos","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2018,5,10]]},"reference":[{"issue":"5","key":"589_CR1","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1016\/0092-8674(91)90397-H","volume":"65","author":"V AJMH","year":"1991","unstructured":"AJMH V, Pieretti M, Sutcliffe JS, Fu Y-H, DPA K, Pizzuti A, Reiner O, Richards S, Victoria MF, Zhang F, Eussen BE, G-JB v O, LAJ B, Riggins GJ, Chastain JL, Kunst CB, Galjaard H, Thomas Caskey C, Nelson DL, Oostra BA, Warren ST. Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome. Cell. 1991;65(5):905\u201314.","journal-title":"Cell"},{"issue":"7","key":"589_CR2","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1136\/jmg.35.7.579","volume":"35","author":"BB de Vries","year":"1998","unstructured":"de Vries BB, Halley DJ, Oostra BA, Niermeijer MF. The fragile X syndrome. J Med Genet. 1998;35(7):579\u201389.","journal-title":"J Med Genet"},{"issue":"4","key":"589_CR3","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1038\/ejhg.2014.185","volume":"23","author":"V Biancalana","year":"2015","unstructured":"Biancalana V, Glaeser D, McQuaid S, Steinbach P. EMQN best practice guidelines for the molecular genetic testing and reporting of fragile X syndrome and other fragile X-associated disorders. Eur J Hum Genet. 2015;23(4):417\u201325.","journal-title":"Eur J Hum Genet"},{"issue":"6","key":"589_CR4","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1093\/hmg\/9.6.901","volume":"9","author":"P Jin","year":"2000","unstructured":"Jin P, Warren ST. Understanding the molecular basis of fragile X syndrome. Hum Mol Genet. 2000;9(6):901\u20138.","journal-title":"Hum Mol Genet"},{"key":"589_CR5","doi-asserted-by":"publisher","first-page":"226","DOI":"10.3389\/fgene.2014.00226","volume":"5","author":"K Usdin","year":"2014","unstructured":"Usdin K, Hayward BE, Kumari D, Lokanga RA, Sciascia N, Zhao XN. Repeat-mediated genetic and epigenetic changes at the FMR1 locus in the fragile X-related disorders. Front Genet. 2014;5:226.","journal-title":"Front Genet"},{"issue":"7","key":"589_CR6","doi-asserted-by":"publisher","first-page":"1648","DOI":"10.1002\/ajmg.a.36511","volume":"164a","author":"J Hunter","year":"2014","unstructured":"Hunter J, Rivero-Arias O, Angelov A, Kim E, Fotheringham I, Leal J. Epidemiology of fragile X syndrome: a systematic review and meta-analysis. Am J Med Genet A. 2014;164a(7):1648\u201358.","journal-title":"Am J Med Genet A"},{"issue":"2","key":"589_CR7","first-page":"171","volume":"36","author":"J Macpherson","year":"1999","unstructured":"Macpherson J, Murray A, Webb J, Jacobs P. Fragile X syndrome: of POF and premutations. J Med Genet. 1999;36(2):171\u20132.","journal-title":"J Med Genet"},{"issue":"2","key":"589_CR8","first-page":"99","volume":"20","author":"A Stembalska","year":"2016","unstructured":"Stembalska A, Laczmanska I, Gil J, Pesz KA. Fragile X syndrome in females - a familial case report and review of the literature. Dev Period Med. 2016;20(2):99\u2013104.","journal-title":"Dev Period Med"},{"issue":"2","key":"589_CR9","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/jhg.2016.122","volume":"62","author":"N Maia","year":"2017","unstructured":"Maia N, Loureiro JR, Oliveira B, Marques I, Santos R, Jorge P, Martins S. Contraction of fully expanded FMR1 alleles to the normal range: predisposing haplotype or rare events? J Hum Genet. 2017;62(2):269\u201375.","journal-title":"J Hum Genet"},{"issue":"6","key":"589_CR10","first-page":"1229","volume":"51","author":"RC Allen","year":"1992","unstructured":"Allen RC, Zoghbi HY, Moseley AB, Rosenblatt HM, Belmont JW. Methylation of HpaII and HhaI sites near the polymorphic CAG repeat in the human androgen-receptor gene correlates with X chromosome inactivation. Am J Hum Genet. 1992;51(6):1229\u201339.","journal-title":"Am J Hum Genet"},{"issue":"1","key":"589_CR11","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.jmoldx.2013.09.004","volume":"16","author":"M Grasso","year":"2014","unstructured":"Grasso M, Boon EM, Filipovic-Sadic S, van Bunderen PA, Gennaro E, Cao R, Latham GJ, Hadd AG, Coviello DA. A novel methylation PCR that offers standardized determination of FMR1 methylation and CGG repeat length without southern blot analysis. J Mol Diagn. 2014;16(1):23\u201331.","journal-title":"J Mol Diagn"},{"issue":"3","key":"589_CR12","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1038\/ng1197-353","volume":"17","author":"RM Plenge","year":"1997","unstructured":"Plenge RM, Hendrich BD, Schwartz C, Arena JF, Naumova A, Sapienza C, Winter RM, Willard HF. A promoter mutation in the XIST gene in two unrelated families with skewed X-chromosome inactivation. Nat Genet. 1997;17(3):353\u20136.","journal-title":"Nat Genet"},{"issue":"7","key":"589_CR13","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1093\/hmg\/ddi089","volume":"14","author":"EM Pugacheva","year":"2005","unstructured":"Pugacheva EM, Tiwari VK, Abdullaev Z, Vostrov AA, Flanagan PT, Quitschke WW, Loukinov DI, Ohlsson R, Lobanenkov VV. Familial cases of point mutations in the XIST promoter reveal a correlation between CTCF binding and pre-emptive choices of X chromosome inactivation. Hum Mol Genet. 2005;14(7):953\u201365.","journal-title":"Hum Mol Genet"},{"issue":"3","key":"589_CR14","doi-asserted-by":"publisher","first-page":"e57977","DOI":"10.1371\/journal.pone.0057977","volume":"8","author":"Z Wang","year":"2013","unstructured":"Wang Z, Yan A, Lin Y, Xie H, Zhou C, Lan F. Familial skewed x chromosome inactivation in adrenoleukodystrophy manifesting heterozygotes from a Chinese pedigree. PLoS One. 2013;8(3):e57977.","journal-title":"PLoS One"},{"issue":"12","key":"589_CR15","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1136\/jmedgenet-2011-100125","volume":"48","author":"AW El-Hattab","year":"2011","unstructured":"El-Hattab AW, Fang P, Jin W, Hughes JR, Gibson JB, Patel GS, Grange DK, Manwaring LP, Patel A, Stankiewicz P, Cheung SW. Int22h-1\/int22h-2-mediated Xq28 rearrangements: intellectual disability associated with duplications and in utero male lethality with deletions. J Med Genet. 2011;48(12):840\u201350.","journal-title":"J Med Genet"},{"key":"589_CR16","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s12881-015-0157-2","volume":"16","author":"AW El-Hattab","year":"2015","unstructured":"El-Hattab AW, Schaaf CP, Fang P, Roeder E, Kimonis VE, Church JA, Patel A, Cheung SW. Clinical characterization of int22h1\/int22h2-mediated Xq28 duplication\/deletion: new cases and literature review. BMC Med Genet. 2015;16:12.","journal-title":"BMC Med Genet"},{"issue":"5","key":"589_CR17","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1016\/j.ajhg.2010.04.006","volume":"86","author":"DT Miller","year":"2010","unstructured":"Miller DT, Adam MP, Aradhya S, Biesecker LG, Brothman AR, Carter NP, Church DM, Crolla JA, Eichler EE, Epstein CJ, Faucett WA, Feuk L, Friedman JM, Hamosh A, Jackson L, Kaminsky EB, Kok K, Krantz ID, Kuhn RM, Lee C, Ostell JM, Rosenberg C, Scherer SW, Spinner NB, Stavropoulos DJ, Tepperberg JH, Thorland EC, Vermeesch JR, Waggoner DJ, Watson MS, Martin CL, Ledbetter DH. Consensus statement: chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies. Am J Hum Genet. 2010;86(5):749\u201364.","journal-title":"Am J Hum Genet"},{"issue":"3","key":"589_CR18","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1002\/humu.22497","volume":"35","author":"L Vanmarsenille","year":"2014","unstructured":"Vanmarsenille L, Giannandrea M, Fieremans N, Verbeeck J, Belet S, Raynaud M, Vogels A, Mannik K, Ounap K, Jacqueline V, Briault S, Van Esch H, D'Adamo P, Froyen G. Increased dosage of RAB39B affects neuronal development and could explain the cognitive impairment in male patients with distal Xq28 copy number gains. Hum Mutat. 2014;35(3):377\u201383.","journal-title":"Hum Mutat"},{"issue":"8","key":"589_CR19","doi-asserted-by":"publisher","first-page":"2444","DOI":"10.1002\/prot.23065","volume":"79","author":"S Witham","year":"2011","unstructured":"Witham S, Takano K, Schwartz C, Alexov E. A missense mutation in CLIC2 associated with intellectual disability is predicted by in silico modeling to affect protein stability and dynamics. Proteins. 2011;79(8):2444\u201354.","journal-title":"Proteins"},{"key":"589_CR20","doi-asserted-by":"publisher","first-page":"e13","DOI":"10.1017\/erm.2015.11","volume":"17","author":"DE Godler","year":"2015","unstructured":"Godler DE, Inaba Y, Schwartz CE, Bui QM, Shi EZ, Li X, Herlihy AS, Skinner C, Hagerman RJ, Francis D, Amor DJ, Metcalfe SA, Hopper JL, Slater HR. Detection of skewed X-chromosome inactivation in fragile X syndrome and X chromosome aneuploidy using quantitative melt analysis. Expert Rev Mol Med. 2015;17:e13.","journal-title":"Expert Rev Mol Med"},{"key":"589_CR21","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/1471-2350-14-80","volume":"14","author":"P Jorge","year":"2013","unstructured":"Jorge P, Oliveira B, Marques I, Santos R. Development and validation of a multiplex-PCR assay for X-linked intellectual disability. BMC Med Genet. 2013;14:80.","journal-title":"BMC Med Genet"}],"container-title":["BMC Medical Genetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12881-018-0589-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12881-018-0589-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12881-018-0589-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,9]],"date-time":"2019-05-09T19:05:43Z","timestamp":1557428743000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedgenet.biomedcentral.com\/articles\/10.1186\/s12881-018-0589-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,10]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["589"],"URL":"https:\/\/doi.org\/10.1186\/s12881-018-0589-6","relation":{},"ISSN":["1471-2350"],"issn-type":[{"type":"electronic","value":"1471-2350"}],"subject":[],"published":{"date-parts":[[2018,5,10]]},"assertion":[{"value":"16 October 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 April 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 May 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Proband\u2019s parents, signed informed consent for the use of DNA samples in intellectual disability research. This study has been approved by the medical ethical committee of the Centro Hospitalar do Porto (CHP, E.P.E.) - REF 2014.203 (144-DEFI\/173-CES).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Proband\u2019s parents, signed informed consent for publication that includes medical information and photographs.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Dr. Paula Jorge is an Associate Editor for BMC Medical Genetics. The remaining authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"74"}}